Search results for "Blood transfusion"

showing 10 items of 100 documents

Transfusion Need at Diagnosis or Its Development During the First Year of Diagnosis in Primary Myelofibrosis: Effect On Survival and Correlation with…

2009

Abstract Abstract 1909 Poster Board I-932 Background: The International Prognostic Scoring System (IPSS) for primary myelofibrosis (PMF) utilizes five independent predictors of inferior survival; of these, a hemoglobin level <10 g/dL has the highest impact on survival (Cervantes et al. Blood 2009;113:2895). In the current study, we examined the additional prognostic impact of transfusion need at diagnosis or becoming transfusion-dependent in the first year of diagnosis. These events were also correlated with JAK2 or TET2 mutational status. Methods: Patients were selected from the Mayo Clinic PMF database based on availability of bone marrow histology and IPSS-relevant information at diag…

medicine.medical_specialtyBlood transfusionbusiness.industryProportional hazards modelmedicine.medical_treatmentImmunologymyelofibrosisTransfusion HistoryCell BiologyHematologyBiochemistrySettore MED/15 - Malattie Del SangueSurgeryTransplantationLog-rank testInternational Prognostic Scoring SystemInternal medicineCohortmedicinebusinessSurvival analysisBlood
researchProduct

Nasal packing in posterior epistaxis. Comparison of two methods

2010

Objective: To evaluate tolerance and efficiency of two nasal blocking systems for posterior refractory epistaxis. Patients and methods: A five year comparative and longitudinal prospective study was developed in patients with epistaxis who attended our Emergency Unit and who required posterior nasal packing. Two groups were considered: one group was treated with a bi-chamber pneumatic inflation system (n=105). In the other one, posterior occlusion was carried out with gauze, accessing through the mouth and using nasal reinforcement (n=47). The tolerance was measured by means of an analogue scale of pain intensity during the placement and maintenance of the packing, as well as for the need o…

medicine.medical_specialtyBlood transfusionbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)General MedicineBalloonNasal packingSurgeryRefractoryConcomitantMedicinePosterior epistaxisbusinessProspective cohort studyActa Otorrinolaringologica (English Edition)
researchProduct

Is cell salvage safe in liver resection? A pilot study

2007

Abstract Study Objective To investigate the quality of cell salvaged (CS) blood in patients undergoing hemihepatectomy (study group) and compare it with CS-blood from aortic surgery (control group). Design Observational study. Setting Operating room in a university hospital. Measurements 6 patients undergoing hemihepatectomy or aortobifemoral bypass with intraoperative blood loss of more than 800 mL. Samples were drawn from the central venous catheter, from the reservoir of a CS recovery system, and from the processed blood in each patient to determine interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor (TNF), complement C3a, and the terminal complement complex C5b-9. Microbiological ana…

medicine.medical_specialtyBlood transfusionmedicine.medical_treatmentCellPilot ProjectsComplement Membrane Attack ComplexResectionBlood Transfusion AutologousmedicineHepatectomyHumansInterleukin-6business.industryInterleukin-8InterleukinBacterial InfectionsInterleukin-10Complement systemSurgeryAnesthesiology and Pain Medicinemedicine.anatomical_structureCytokineComplement C3aErythrocyte TransfusionbusinessAnaerobic exerciseCentral venous catheterJournal of Clinical Anesthesia
researchProduct

Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?

2014

Summary Leishmaniasis clinical spectrum ranges from cryptic infection to fatal visceral leishmaniasis. Cryptic infection can be found in blood donors from areas endemic for leishmaniasis all over the world. Although leishmaniasis is a classic vector-borne disease, cases of transfusion transmitted leishmaniasis have been reported especially in nonendemic areas. Most of these cases regarded infants or children. This paper reviews the literature on this specific feature and the impact of leishmaniasis on transfusion medicine. Relevant literature was found through PubMed. The reference lists of selected articles identified further sources. Conclusions: Blood donations by emigrants or travelers f…

medicine.medical_specialtyLeishmaniasiSettore MED/09 - Medicina InternaBlood DonorsDiseaseBlood donationsmedicineAnimalsHumansTravel medicineBlood TransfusionIntensive care medicineLeishmaniabiologyTransfusion Medicinebusiness.industryPublic Health Environmental and Occupational HealthTransfusion medicineLeishmaniasismedicine.diseaseLeishmaniabiology.organism_classificationtransfusion blood donorCryptic infectionBloodInfectious DiseasesVisceral leishmaniasisLeishmaniasis; transfusion blood donors;ImmunologyLeishmaniasis Visceralbusiness
researchProduct

Pathogen safety of long-term treatments for bleeding disorders: (un)predictable risks and evolving threats.

2013

Substantial improvements in the safety of blood and plasma products for the management of bleeding disorders have been achieved in recent decades. This has led some clinicians to believe that the infectious threat is over and that inhibitor formation is the foremost complication of hemophilia therapy. On the contrary, elimination of all microbes from blood is difficult, potentially impossible, and there are always threats from emerging pathogens. The risk of infection transmission is also increasing due to greater exposure to products, increasing prophylaxis and high-dose regimens for immune tolerance, and longevity of hemophilia patients. Current products can be considered "reasonably safe…

medicine.medical_specialtyLong term treatmentContext (language use)Hemophilia AInfectionsEmerging infectionsSAFERHumans; Blood Coagulation Disorders; Hemophilia A; Blood Transfusion; InfectionmedicineHumansBlood TransfusionIntensive care medicinePathogenTransmission (medicine)business.industryRisk of infectionTransfusion ReactionHematologyBlood Coagulation Disordersmedicine.diseaseSettore MED/07 - Microbiologia e Microbiologia ClinicaThrombosisSurgeryHemostasisPlasma productsBlood safetyCardiology and Cardiovascular MedicinebusinessInfectionSeminars in thrombosis and hemostasis
researchProduct

Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: A narrative review.

2020

Background The periorbital region is among the first areas to be affected by the process of aging, which is influenced by genetic and constitutional factors. As the region plays an important role in overall facial appearance, rejuvenation of the area has immense cosmetic benefit and various treatment modalities have been used to achieve the same. Aims This article reviews commonly used non-surgical and minimally invasive modalities for periorbital rejuvenation. Methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles.…

medicine.medical_specialtyMEDLINEDermatologyCosmetic TechniquesPeriorbital rejuvenation030207 dermatology & venereal diseases03 medical and health sciencesBlood Transfusion Autologous0302 clinical medicineMedicineHumansRejuvenationRejuvenationModalitiesModality (human–computer interaction)business.industryPlatelet-Rich PlasmaDermatologySkin AgingClinical trialTreatment Outcome030220 oncology & carcinogenesisPlatelet-rich plasmaFaceNarrative reviewbusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Chelation treatment in sickle-cell-anaemia: much ado about nothing?

2011

Summary Blood transfusions may prevent and treat serious complications related to sickle-cell disease (SCD) when performed according to specific guidelines. However, blood transfusion requirements in SCD inevitably lead to increased body iron burden. An adequate chelation treatment may prevent complications and reduce morbidity and mortality. This review evaluates the effectiveness, safety and costs of chelation treatment. The included trials were examined according to the recommendations of the American College of Cardiology (ACC) and the American Heart Association (AHA). Overall, 14 trials and a total of 502 patients with SCD were included in this review. Deferoxamine alone (s.c. or i.v.)…

medicine.medical_specialtyPediatricsBlood transfusionDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentAnemia Sickle CellDiseaseIron Chelating Agentslaw.inventionBody ironchemistry.chemical_compoundRandomized controlled triallawmedicineHumansChelationIntensive care medicinebusiness.industryDeferasiroxHematologyChelation TherapyDeferoxamineTreatment OutcomechemistryCosts and Cost AnalysisDeferipronebusinessChelation treatment sickle-cell-diseasemedicine.drug
researchProduct

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

2021

medicine.medical_specialtybusiness.industryThalassemiabeta-ThalassemiaMEDLINEHematologymedicine.diseaseInternal medicineCause of DeathTransfusion dependencemedicineHumansBlood TransfusionBlood Transfusion; Cause of Death; Humans; beta-ThalassemiabusinessLetters to the EditorHaematologica
researchProduct

Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant …

2020

GETH (Grupo Español de Trasplante Hematopoyético y Terapia Celular).

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatment1700Antibioticslcsh:MedicinemicrobiomeGraft vs Host DiseaseHematopoietic stem cell transplantationantibioticsAntimicrobial StewardshipFecesInternal medicinegraft versus host diseasemicrobiotamedicineHumansMulticenter Studies as Topic1506infectionsLongitudinal StudiesProspective StudiesAntibiotic prophylaxisbusiness.industryIncidence (epidemiology)lcsh:RHematopoietic Stem Cell TransplantationGeneral MedicineAntibiotic Prophylaxismedicine.diseaseTransplant RecipientsGastrointestinal MicrobiomeTransplantationObservational Studies as Topicsurgical procedures operativeGraft-versus-host diseaseResearch DesignCase-Control StudiesCohortObservational studybusinessHaematology (Incl Blood Transfusion)BMJ Open
researchProduct

Częstość wykonywania zabiegu transfuzji uzupełniającej u noworodków donoszonych i przedwcześnie urodzonych w latach 2012–2016 na podstawie analizy do…

2018

Wprowadzenie. Transfuzja krwi jest częstym zabiegiem u noworodków. Osoba podejmująca decyzję o jego przeprowadzeniu musi być świadoma, że ratuje on życie i jest obciążony wieloma powikłaniami. Cel pracy. Określenie częstości wykonywania transfuzji uzupełniających u noworodków leczonych na Od-dziale Anestezjologii i Intensywnej Terapii Dzieci i Noworodków (OAITDiN) w Uniwersyteckim Szpitalu Klinicznym w Opolu latach 2012–2016. Ustalenie, czy istnieje istotna zależność między wiekiem noworodka a liczbą transfuzji. Zidentyfikowanie najczęstszych wskazań do przeprowadzenia transfuzji. Materiał i metody. Przeprowadzono analizę retrospektywną dokumentacji medycznej techniką nowoczesną polegającą …

noworodkiprzetaczanie krwinewbornblood transfusionneonatal intensive care unitoddział intensywnej opieki nad noworodkiemPielęgniarstwo i Zdrowie Publiczne
researchProduct